This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Rhona C Kabakoff: Innovator in Asthma Treatment
Introduction
Rhona C Kabakoff is a prominent inventor based in Pacifica, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of asthma. Her innovative work has led to the development of a unique therapeutic approach that utilizes monoclonal antibodies.
Latest Patents
Rhona holds 1 patent for her invention titled "Anti-IL-8 monoclonal antibodies for treatment of asthma." This patent outlines methods for treating asthma using anti-IL-8 monoclonal antibodies, showcasing her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Rhona is currently associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her role at Genentech has allowed her to work on groundbreaking research that has the potential to change the landscape of asthma treatment.
Collaborations
Throughout her career, Rhona has collaborated with notable colleagues, including Caroline Alice Hebert and Mark W Moore. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.
Conclusion
Rhona C Kabakoff's contributions to asthma treatment through her innovative patent and work at Genentech highlight her as a key figure in the field of medical research. Her dedication to improving health outcomes continues to inspire advancements in the treatment of asthma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile